Sanro Health, a clinician-founded health technology company, announced a strategic investment from Topcon Healthcare.
Sanro Health addresses one of healthcare’s biggest challenges by uniting fragmented ophthalmic clinical data and medical images to make data both usable and actionable to drive better outcomes for patients. This unified framework preserves patient context, ensures data integrity, and enables trustworthy, interoperable biomarker discovery. Together, Sanro Health and Topcon Healthcare aim to make connected, standards-based data the foundation for better patient care and clinical research.
Sanro Optimizer Enables Real-Time Clinical Trial Recruitment
Sanro Optimizer, the company’s first product, integrates electronic health record and imaging data to create intelligent patient profiles and ranked cohorts, identifying eligible participants for clinical trials in real time during routine patient care across eyecare providers. This capability establishes a foundation for real-world AI, leveraging Sanro’s proprietary AI and interoperability framework to enable personalized research and care.
“Sanro Health’s deep understanding of ophthalmic data, and proven ability to deliver real-world clinical data and medical image interoperability make them an ideal partner,” said Ali Tafreshi, CEO & President of Topcon Healthcare. “By linking these data sets using agreed data standards, we can transform how patient care and research interconnect.”
“Every patient’s history tells a story, but too often that story is fragmented,” said Dr. Ashley Kras, Co-Founder and CEO of Sanro Health. “Sanro connects and interprets data so clinicians can see the full picture and researchers act faster. With Topcon Healthcare’s support, we’re building the connected data infrastructure across eyecare providers that healthcare needs today.”
This partnership strengthens Topcon Healthcare’s efforts to advance its Healthcare from the Eye strategy while accelerating Sanro Health’s U.S. expansion and product development, supporting rollout across leading clinical and research networks.
